I caught that show the other day. The CEO
mainly just went on about Enbrel prospects,
implied that there may be a pop with sales
initially for all the folks who test drive
the product, but was also very optimistic
that a lot of folks with RA would make the
switch. He also went on about the postcards
etc they have received from grateful patients,
and of course talked about juvenile arthritis.
Mainly a feel good presentation...he even had
the confidence to suggest that Mitzman would
have him on again next year...that would be
three appearances each year right in a row,
which is not very likely.
I am 90% sure that it was he, and not the ceo
of Pathogenesis, who stated that they were looking
at aquisitions. Barry Mitzman pressed him on this and
he said something like well this would not be
happening until 2000, to which Mitzman said
that's only a year away, blah blah blah.
No science, not even enough science was in the
discussion for a biotech newbie like myself.
So, if anybody wants to read about TNF (at
least the acronym "TNF" was quickly blurted out...)
here is the Enbrel prescription url
enbrelinfo.com |
